by cloning the DNA sequence coding for amino acid residues 1-389 of diphtheria toxin from Corynebacterium diphtheriae, including the inactivating mutation G79D, between NI 1 C and Ac2 in pQIq. The amino acid sequence 1-389 encompasses both the inactivated catalytic domain and the T-domain responsible for protein translocation, but not the original receptor-binding domain. The diphtheria toxin gene fragment was purchased as a gene from Genscript. DNA blocks containing the tat and penetratin sequences were ordered from Integrated DNA Technologies. PCR amplicons prepared from these DNA blocks containing the required restriction sites were used for the construction of penetratin-NI 1 C, tat-NI 1 C, tat-Ec1-NI 1 C, tat-ETA(252-412)-NI 1 C and tat-Ec1-ETA(252-412)-NI 1 C in pQIq 2 . The DNA sequence of supercharged GFP (scGFP) (+36) was based on a published protein sequence 3 and ordered as a DNA block from Geneart (Life Technologies). It was inserted into the pQIq vector between an N-terminal MRGS-His 6 and C-terminal avi and HA sequences, resulting in the scGFP construct. The model cargo DARPin NI 1 C was introduced C-terminally by PCR. The scGFP and scGFP-NI 1 C stretches were transferred into a pQIq vector with an N-terminal Ec1 fusion, yielding Ec1-scGFP and Ec1-scGFP-NI 1 C. A Tobacco Etch Virus (TEV) protease cleavage site (ENLYQFG) was introduced by PCR between Ec1 and scGFP to produce Ec1-scGFP-NI 1 C and Ec1-scGFP variants that yielded scGFP-NI 1 C and scGFP after TEV protease cleavage (see below for further details). The cloning of PA-Ac2 and LF1-254-NI 1 C and LF1-254-NI 2 C-dest has been described before 2 . PA sAntrx -Ac2 was prepared by genetic fusion of the soluble part of anthrax toxin receptor 2 (residues 40-217), bearing the mutation C175A, to wild-type protective antigen by a (G 4 S) 5 linker with a length of ~88 Å, and followed by the EpCAM-targeting DARPin Ac2. A more extensive description of design features and the characterization of this particular protective antigen variant will be published elsewhere.
Protein expression
E. coli strain BL21 (DE3) was transformed with all plasmids for expression, except those that contained an ETA translocation domain (252-412), for which the E. coli strain Origami B (DE3) was used. A single clone was picked on the next day and used for the inoculation of 50 mL overnight cultures in lysogeny broth (LB) medium containing 1% (w/v) D-glucose and supplemented with 100 µg/mL ampicillin (BL21 (DE3)) or 100 µg/mL ampicillin and 15 µg/mL kanamycin (Origami B (DE3)). On the next day, the overnight culture was used to inoculate 1 L of terrific broth (TB) medium (OD 600 after inoculation ~ 0.1) for expression, supplemented with 0.8% (w/v) D-glucose and antibiotics. The cultures were grown at 37°C until an OD 600 of 0.6 to 0.8 was reached, at which point expression was induced with 500 µM isopropyl-β-thiogalactoside (IPTG) and the temperature was lowered to 25°C. After 4 h of expression, the cultures were centrifuged, shock-frozen and stored at -80°C until purification.
Protein purification
A schematic overview of the purification strategies of the various proteins is given in or an in-house designed homogenizer in 1 to 3 cycles. The cell debris was removed by centrifugation at 4°C for 40 min at 28,000 × g, and subsequent filtration through 0.22 µm pore-sized membranes (Merck Millipore). A benchtop IMAC procedure was performed as described 2 . The protein purity was assessed by staining of SDSpolyacrylamide gels with Coomassie blue dye ( Fig. 3) and the OD 260 /OD 280 ratio as determined with a NanoDrop ® 2000 spectrophotometer (Thermo Fisher Scientific).
All constructs were found to be over 90% pure as estimated by Coomassie blue staining, except for penetratin (~ 70 % pure) and scGFP constructs. scGFP constructs were further purified by cation exchange, as described below.
TEV Protease Cleavage:
Two scGFP-based constructs, scGFP and scGFP-NI 1 C, were expressed with an N-terminal Ec1-DARPin followed by a TEV protease cleavage site, ENLYQFG, as the expression without the solubility-enhancing N-
terminal DARPin was unsuccessful. The purification of TEV protease has been described elsewhere 2 . TEV protease cleavage was accomplished overnight at 4°C at a 10:1 (w/w) ratio of protein to TEV protease in a sodium acetate -acetic acid buffer, pH 5.6, containing 0.2 or 0.5 M NaCl and supplemented with 0.5 mM EDTA and 1 mM DTT. Success of TEV cleavage was checked by Coomassie blue-staining of SDS polyacrylamide gels and was typically complete.
Cation exchange chromatography: Constructs based on scGFP were less than 90% pure as assessed by Coomassie blue staining and were further purified by cation exchange chromatography. IMAC-purified and TEV protease-cleaved scGFP-based constructs were applied to the strong cation-exchanger column Mono S 5/50 GL (GE Healthcare) using an ÄKTA pure or ÄKTA explorer system (GE Healthcare). The column was equilibrated with 10 column volumes of PBS buffer containing 0.5 M NaCl (pH 7.4). Protein samples were diluted to 0.5 M NaCl in PBS prior to directly loading them onto the column, which was followed by washing with 20 column volumes with PBS containing 0.5 M NaCl. Elution was carried out with a linear gradient of 0.5 M NaCl to 2 M NaCl (all in PBS) over 10 column volumes (Supplementary Fig. 3 ). Protein fractions were combined and dialyzed back to PBS with 2 M NaCl.
Removal of proteins already biotinylated in the production host E. coli:
The fraction of expressed protein that was biotinylated due to the activity of native biotin ligase in E. coli was removed from all proteins using a streptavidin resin (Genscript)
as described previously 2 . For penetratin-NI 1 C and tat-Ec1-ETA-NI 1 C, the published procedure was unsatisfactory. We hypothesized that a small biotinylated fraction Since transfection levels (and thus protein levels) were very low for HT29 cells, the lysates were analyzed directly using fluorescently labeled streptavidin-LT680, which provides a more sensitive 
